Is Paxlovid Worth It? A Critical Look at the COVID-19 Antiviral
•
3 min read
According to initial clinical trials, Paxlovid reduced the risk of hospitalization or death by nearly 90% in unvaccinated, high-risk individuals with mild-to-moderate COVID-19. Given its demonstrated benefits, the question for many remains: **Is Paxlovid worth it?**
